IKON Group Investments — Global Holdings Company

IKON Market Brief: OpenEvidence launches medical AI copilot feature that grades medical evidence and unveils NewYork-Presbyterian collaboration

Posted by:

|

On:

|

OpenEvidence developed a medical AI copilot feature that provides a real-time assessment of the strength of the evidence behind each applicable answer.

Source: www.fiercehealthcare.com

IKON Portfolio Context

Our healthcare vertical includes Renew Republic Health (precision medicine, TRT, peptide therapy) and Renew Lab Group (pharmaceutical testing), both headquartered in Houston, Texas.

Posted by

in